Auxly Cannabis Group Inc. · TSX:XLY
Auxly Cannabis — Investor Presentation (May 2021)
24 slides from Auxly Cannabis's investor presentation, May 2021
Slide 1: This is Auxly. Investor Presentation
This ts Auxly. Investor Presentation Auxly
Slide 2: Disclaimer and forward-looking information
ward- looking information, general business, The information provided herein is not intended to This corporate document contains economic and competitive uncertainties, provide financial, tax, legal or accounting advice. “foward-looking statements” and regulatory risks including risks related to the
Slide 3: Our winning formula
Our winning formula: The best team, assembled from cannabis enthusiasts and entrepreneurs, CPG professionals and renowned scientists and researchers, all with a shared commitment to quality and our consumers; the best strategy, dialed-in and focused on knowing where the consumer is headed; and the b
Slide 4: Our Vision and Mission
Our Vision: Auxly’s vision is to be a global leader in branded cannabis products that deliver on our consumer promise of quality, safety and efficacy. Our Mission: Supporting the health and happiness of our consumers by providing the quality branded cannabis products they trust and love. This is Aux
Slide 5: Auxly Snapshot
Auxly Snapshot We operate state-of-the-art cultivation, extraction, processing and manufacturing facilities across the eastern provinces and collaborate with the country’s finest craft growers to bring consistent, effective, high-quality cannabis products to Canadian consumers. ASSET RaD CULTIVATION
Slide 6: 2020 in Review
#1 LP in 2020 for Cannabis 2.0 Product! Sales with 14% share of the National 2.0 Market 19% National market share in Vapes One of the first LPs to market with In Review 2.0 products Launched its new Launch of brand, Back Kolab Project’s Forty, with three " _Launch of : grower series unique, high- ‘a
Slide 7: Top Performing LP in Cannabis 2.0 Product Sales
Top Performing LP in Cannabis 2.0 Product1 Sales and Building to Leadership in the Total Cannabis Industry 18% $36,000,000 16% $31,000,000 14% $26,000,000 12% 10% $21,000,000 8% $16,000,000 6% $11,000,000 4% $6,000,000 2% 0% $1,000,000 Q1 2020 Q2 2020 Q3 2020 Q4 2020 Q1 2021 2.0 Market Share Total M
Slide 8: Earnings Snapshot
Earnings Snapshot / Investor Presentation
Slide 9: Strong growth in cannabis net revenue
Strong growth in cannabis net revenue Cannabis Net Revenue by Quarter $20 $15 4 2020 $10 Q3 2020 q Qi 2020 $5 Q2 2020 $0 (Millions) XLY Cannabis Net Revenue Path to Profitability Build upon our success Drive the company's Bring consumer-focused Leverage the Sunens Targeting 30% Continue to improve a
Slide 10: Our Product Categories
Our Product Categories - Consistent, High-Quality And Unique \VAPES: Two ingredients: EDIBLES: Made with natural, high-quality cannabis traceable ingredients and distillate and terpenes. high-quality cannabis Available in0.3,0.5 and1.0g distillate. Our portfolio sizes,and a variety of strains includ
Slide 11: Cannabis 2.0 sales accounted for 19% of the Total Market
Cannabis 2.0 sales accounted for Topicals: 0.3% Edibles: 4% 19% of the Total Market. Pre Rolls: 17% Beverages: 1.3% Capsules/oils: 5.7% The Canadian cannabis market is Cannabis 2.0 products continue to gain Concentrates projected to reach $10bn in sales by strong market share as new product includin
Slide 12: Ottawa pre-roll manufacturing facility
Auxly’s facility located in Ottawa, Ontario is completely focused on pre-roll product manufacturing. / Investor Presentation
Slide 13: Dosecann product formulation and manufacturing
Dosecann is Auxly’s state-of-the art center for cannabis product formulation and manufacturing. At every stage of product development, the experience of the end-user is what we care about the most. Dosecann is committed to providing consumers with quality products backed by science and advanced rese
Slide 14: Continuously evolving our portfolio to meet consumer demands
Continuously evolving our portfolio to meet consumer demands / Investor Presentation
Slide 15: Leveraging partnerships with industry leaders
Leveraging our partnerships with industry leaders allows Auxly to better optimize its portfolio and build powerful consumer value propositions. / Investor Presentation
Slide 16: We build brands that connect
We build brands that connect. Accompanying consumers on their cannabis journeys, our commitment is to continually develop our brands to maintain an authentic connection. This is Auxly / Investor Presentation 16 Auxly
Slide 17: Kolab Project
KOLAB PROJECT A refined collection of high quality cannabis products and design-focused, purposeful goods. We connect consumers with a carefully selected group of collaborators in order to create products that are inspired by their ever-evolving needs. AVAILABLE NOW Pre-Rolls: Dried Flower: Vapes: C
Slide 18: Back Forty
Slide 19: Foray
Foray Foray is a versatile, modern, and inviting cannabis brand, designed for the curious. Foray is an accessible entry point for anybody—at any stage of their cannabis journey. Designed for the curious, Foray is an approachable brand that aims to both celebrate and guide one’s foray into cannabis,
Slide 20: Dosecann
Slide 21: Robinsons
ROBINSONS Proudly situated in the heart of Nova Scotia's Annapolis Valley, Robinsons is a Canadian producer of fine cannabis. Always small-batch and hand-tended, our product is grown for and best enjoyed by the discerning consumer. Driven by an unwavering commitment to craftsmanship, our focus has a
Slide 22: Capitalization Table
Capitalization Table AMOUNT ($ MILLIONS) AMOUNT (UNIT) PERCENTAGE COMMON SHARES OUTSTANDING! $299.88 749.71M 71.3% STOCK OPTIONS (WEIGHTED AVERAGE EXERCISE PRICE OF $0.902)? $27.28 30.76M 2.9% WARRANTS (WEIGHTED AVERAGE EXERCISE PRICE OF $0.593) $45.67 82.48M 7.9% IMPERIAL BRANDS CONVERTIBLE DEBENTU
Slide 23: Board of Directors
Board of Directors Genevieve Young Chair Genevieve is the President and Chief Operating Officer of Global Public Affairs, Canada’s leading privately held strategic communications and government advocacy consultancy representing some of Canada’s largest and most dynamic organizations. Genevieve has t
Slide 24: Auxly contact details
Auxly Auxly Cannabis Group 777 Richmond St W Unit 002 Toronto Ontario M6J 0C2 Investor Relations Direct Line 1647 8120121 Facsimile Line 1 855 669 7881 Email [email protected] May 2021
Auxly Cannabis Group — Investor Presentation (May 2021) on 6ix